Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When greater than 11.4 ng/mL, the sBT is considered elevated”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [41]
In the citing paper
“and a level greater than 20 ng/mL is a minor diagnostic criterion for SM.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [41]
Citations
Cites
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,005
Self-citationNagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Self-citationDecrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.447 · Cited by 608
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz, L. B., Irani, A. M. A., Roller, K., Castells, M. C., & Schechter, N. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2611 · Cited by 500
Self-citationSystemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEW
TRAVIS, W. D., LI, C.-Y., BERGSTRALH, E. J., YAM, L. T., & SWEE, R. G. (1988) · Medicine · doi:10.1097/00005792-198811000-00001 · Cited by 488
Schwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114051 · Cited by 456
Self-citationValent, P., Spanblochl, E., Sperr, W., Sillaber, C., Zsebo, K., Agis, H., Strobl, H., Geissler, K., Bettelheim, P., & Lechner, K. (1992) · Blood · doi:10.1182/blood.v80.9.2237.2237 · Cited by 439
Research works printed but not linked: 2
- Buckley, 1999, The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase, J. Pathol., 189, 138, 10.1002/(SICI)1096-9896(199909)189:1<138::AID-PATH400>3.0.CO;2-H · doi:10.1002/(sici)1096-9896(199909)189:1<138::aid-path400>3.0.co;2-h
- Nagata, 1995, Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder, Proc. Natl. Acad. Sci. USA, 92, 10560, 10.1073/pnas.92.23.10560 · DOI · Paper page
Cited by
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationValent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationAnaphylaxis—a practice parameter update 2015
Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474
Anaphylaxis During the Perioperative Period
Hepner, D. L., & Castells, M. C. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000082993.84883.7d · Cited by 375
“However, one study reported levels of b-tryptase >10 ng.ml)1 in five of 49 cases thought to be non- anaphylactic deaths [ 2 ].”
BackgroundMethodInfluentialMast cell tryptase: a review of its physiology and clinical significance
Payne, V., & Kam, P. C. A. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03757.x · Cited by 320
Metadata
- Authors
- Schwartz, L. B.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Schwartz, Lawrence B.
- Venue
- Leukemia Research
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 25
- Issue
- 7
- Pages
- 553-562
- ISSN
- 0145-2126 (ISSN-L)
- OpenAlex
- W2160237816
- Cited by
- 110
- References
- 94
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 1 · 2021: 7 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 4 · 2012: 4
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Leukemia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Rheumatology › Eosinophilic Disorders and Syndromes
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- systemic mastocytosis, mast cell activation syndrome, tryptase, mast cell activation, diagnostic criteria, sensitivity and specificity, misdiagnosis
- MeSH terms
- Anaphylaxis, Animals, Apnea, Child, Preschool, Enzyme Activation, Enzyme Induction, Enzyme Precursors, Clinical Enzyme Tests, Hematologic Diseases, Humans, Hyperplasia, Immunoassay, Infant, Isoenzymes, Mast Cells, Mastocytosis, Protein Conformation, Protein Processing, Post-Translational, Serine Endopeptidases, Sudden Infant Death, Biomarkers, Proto-Oncogene Proteins c-kit, Cell Lineage, Mice, Tryptases, Chymases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. https://app.cochat.ai/papers/10.1016/s0145-2126(01)00020-0
- The paper
- Schwartz, L. B. (2001). Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leukemia Research. https://doi.org/10.1016/s0145-2126(01)00020-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.